| abstract |
Use of a purified extract of hibiscus with a polyphenol titer greater than or equal to 50% and an organic acid titer less than or equal to 30%, for the preparation of a medicinal product intended for the treatment or prevention of urinary tract infections related to the presence of Escherichia coli and Candida albicans, said purified hibiscus extract, being obtained after carrying out the following steps: - Extraction by maceration of the entire plant in fresh or dry form, or of the hibiscus flowers, in a solvent constituted by alcohol or by a hydroalcoholic mixture, then - Separation of the solvent and the plant in order to obtain a crude extract, then - Purification of the crude extract by chromatography on an adsorption / desorption resin, or by liquid extraction / liquid in an organic solvent not miscible in water. |